Breaking News on Pharmaceutical Technology

Latest news headlines

Products

Suppliers

Biomanufacturing sales key to Pall’s Q4 growth

15-Sep-2010 - Pall has ended fiscal 2010 with strong set of sales after recovering pharmaceutical industry demand for bioproduction tech maintained its momentum in Q4

Q Chip scaling up cGMP production using new funding

15-Sep-2010 - Q Chip is using new funding to scale up its Q-Sphera technology for cGMP production of sustained release peptide and protein therapeutics.

Grace to buy Synthetech for chiral expertise

14-Sep-2010 - Industrial catalysis firm WR Grace moves for struggling Synthetech to boost pharmaceutical intermediates and chiral chemistry offering.

Exclusive interview

Thermo to add sites in China to fulfil APAC aspirations

07-Sep-2010 - Extension of a production site in Shanghai is a small part of the big aspirations Thermo has for China and Asia Pacific.

Bend receives patent for making spray-dried drug dispersions using pressure nozzles

02-Sep-2010 - US formulation services provider Bend Research has received a new patent for the process of producing spray-dried solid amorphous dispersions of drugs using single-fluid pressure nozzles.

BI opens ‘Centre of Competence’ opens as part of a €100m China plan

02-Sep-2010 - Boehringer Ingelheim has opened its ‘Centre of Competence’ (CoC) in Shanghai to optimise API and chemical intermediates sourcing in China.

iBio, GE partner to work on plant-based production tech

02-Sep-2010 - iBio, CMB and GE Healthcare are collaborating on developing and marketing biopharm production systems, including plant-based expression technology.

Prosonix launches ultrasound-assisted co-crystal service

01-Sep-2010 - Prosonix has launched a co-crytsallisation service for the production of APIs for inhalable drugs and oral medicines.

NanGenex adds bench-top, pilot nano API production tech

01-Sep-2010 - NanGenex is introducing GMP bench-top and pilot plant reactors to scale-up its process for the continuous production of nanostructured active ingredients.

News in brief

SK opts for Xcellerex’ tech for vac production

31-Aug-2010 - SK Chemicals hopes Xcellerex’ manufacturing technology will boost vaccine production business.

US gov support needed for overhaul of vacc production

31-Aug-2010 - Cell culture, LAIV vaccines and recombinant DNA technology should be supported by the US government as part of a long-term overhaul of pandemic response capabilities, according to PCAST.

Mtech adds non-GMP capacity for Maryland biotechs

26-Aug-2010 - Mtech Bioprocess is to double scale-up square footage and staff to support Maryland, US biotechs’ non-GMP production work.

Pandemic vaccine production time could be halved in 3 years

25-Aug-2010 - A review of US capabilities has concluded that the time to produce a pandemic vaccine could be halved through adoption of short-term policies.

HHS allocates $2bn to overhaul pandemic response process

23-Aug-2010 - The US HHS is allocating $2bn (€1.6bn) to overhaul pandemic and bioterrorism capabilities through improvements to regulatory, developmental and manufacturing processes.

News in brief

Mettler says in-line granulation monitoring can cut time to market

23-Aug-2010 - Mettler Toledo’s new in-line granulation monitoring tech may make in-process particle characterisation less of a grind.

CardioGenics “biologics beads” to change antibody extraction landscape

18-Aug-2010 - CardioGenics predicts yield boosting “biologics beads” will change the antibody extraction landscape after signing distribution deal with Merck Chimie.

Octapharma licenses new BAC purification ligand

17-Aug-2010 - Bioprocess purification chromatography tech wins BAC new deal after Swiss protein maker Octapharma licenses it for commercial-scale manufacture.

BARDA funding vaccine capacity creation in developing world

12-Aug-2010 - BARDA is providing the WHO with $6.4m (€5.0m) to cooperatively develop influenza vaccine production capacity in under-resourced nations.

Medicago to build 90,000 sq ft vaccine plant in RTP

11-Aug-2010 - Medicago is to build a 90,000 sq ft cGMP vaccine facility in RTP, North Carolina, US using a $21m (€16.1m) grant from the US Department of Defense.

Cel-Sci completes first Multikine batch at "Cold Fill" plant

05-Aug-2010 - Cel-Sci’s recently opened “Cold fill” facility has passed its first manufacturing test by completing filling of a batch of the candidate head and neck cancer drug Multikine for a late-stage trial.

Pfenex inks US anthrax vaccine production contract

04-Aug-2010 - Pfenex has won a US federal contract to use its expression technology for the rapid, cost-effective production of “unprecedented” amounts of anthrax vaccine.

Cancer Research UK opens biopharm production unit

02-Aug-2010 - Cancer Research UK has established a £18m ($28.4m) biopharm manufacturing unit to produce complex experimental drugs, such as monoclonal antibodies.

News in brief

Heinkel boosts separation offering with Comber buy

02-Aug-2010 - Heinkel expands pharmaceutical filtering and drying systems business with acquisition of Italian equipment maker Comber.

ATMI doubles bioprocess tech manufacturing capacity

29-Jul-2010 - ATMI completes expansion at US bioprocess tech plant days after citing life science business growth as an important part of its second quarter gains.

Celleuxs launches “broad cell line” disposable bioreactor

28-Jul-2010 - Cellexus has expanded its disposable bioreactor offering with a unit designed to give biomanufacturers greater flexibility in their choice of cell lines.

Sign up for your free newsletter